Rakesh Doshetty
Interventional Cardiology · Chicago, ILNPI 1174906515
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,395 of the $10,178 with a category attached, or 62.8%. It is spread thinly across 29 manufacturers, the largest accounting for just 23.4%. 2025 is the largest year on record at $5,385, more than ten times the $521 reported in 2019.
Across 168 payments — averaging $60.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- Abbott$2K
- Abiomed$2K
- Shockwave Medical, Inc$634
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$520
- Johnson & Johnson$358
- plus $2K from 23 others
What the payments were for
- Travel & lodging$3,29132%
- Food & beverage$6,39563%
- Education$4925%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 9 | $2,384 |
| Abbott | 18 | $2,345 |
| Abiomed | 15 | $1,733 |
| Shockwave Medical, Inc | 15 | $634 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 16 | $520 |
| Johnson & Johnson | 11 | $358 |
| AstraZeneca | 16 | $312 |
| Pfizer | 7 | $230 |
| Novartis | 11 | $230 |
| Boston Scientific | 2 | $212 |
| Merck | 11 | $198 |
| Medtronic | 7 | $130 |
| Teleflex LLC | 1 | $121 |
| Cardiovascular Systems Inc. | 1 | $117 |
| Stryker | 3 | $99 |
| Amgen | 4 | $75 |
| E.r. Squibb & Sons, L.L.C. | 4 | $71 |
| Boehringer Ingelheim | 3 | $68 |
| Cleerly, Inc. | 1 | $64 |
| Kestra Medical Technology Services, Inc. | 2 | $46 |
| Lantheus Medical Imaging, Inc. | 3 | $41 |
| Bayer | 1 | $35 |
| Corcept Therapeutics | 1 | $30 |
| Cook Medical LLC | 1 | $28 |
| Astellas Pharma US Inc | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $22 |
| Vital Connect, Inc | 1 | $17 |
| Argon Medical Devices, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,178 in reported general payments places this provider in the 55th percentile of 303 interventional cardiology providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 24 | $313 |
| Atorvastatin Calcium | 21 | $99 |
| Lisinopril | 13 | $94 |
| Carvedilol | 12 | $56 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Chicago
- Atman ShahChicago$788K
- David StewartChicago$169K
- Hussam SuradiChicago$97K
- Anita AsgarChicago$85K
- Daniel SchimmelChicago$79K
- Ranya SweisChicago$62K
- Charles DavidsonChicago$62K
- Fareed Moses ColladoChicago$42K
- James FlahertyChicago$38K
- Ashvarya ManglaChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.